The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Augmentation of therapy for favorable-histology Wilms Tumor with combined loss of heterozygosity of chromosomes 1p and 16q: A report from the Children’s Oncology Group studies AREN0532 and AREN0533.
 
David B. Dix
No Relationships to Disclose
 
Conrad Vincent Fernandez
Stock and Other Ownership Interests - DiagnoCure (I)
 
Yueh-Yun Chi
No Relationships to Disclose
 
James Robert Anderson
Consulting or Advisory Role - Amgen; Merck; SFJ Pharmaceuticals Group
 
Elizabeth Anne Mullen
No Relationships to Disclose
 
James I. Geller
Consulting or Advisory Role - Bayer
Research Funding - Pfizer
 
Eric J. Gratias
Employment - MedSolutions, Inc.
 
Geetika Khanna
Research Funding - BioMedical Systems
 
John A. Kalapurakal
Honoraria - Elekta
 
Elizabeth Jones Perlman
No Relationships to Disclose
 
Nita Seibel
No Relationships to Disclose
 
Peter F. Ehrlich
No Relationships to Disclose
 
Marcio H. Malogolowkin
No Relationships to Disclose
 
Kenneth William Gow
Stock and Other Ownership Interests - Amgen (I)
 
Thomas Edward Hamilton
No Relationships to Disclose
 
Paul Edward Grundy
No Relationships to Disclose
 
Jeffrey Dome
Research Funding - Rockland Immunochemicals; St. Jude Children's Research Hospital